Expression of integrin αvβ3 in gliomas correlates with tumor grade and is not restricted to tumor vasculature

Brain Pathology

Volumn 18, Issue 3, 2008, Pages 378-386

  Schnell, Oliver ^b   Krebs, Bjarne ^a   Wagner, Erika ^b   Romagna, Alexander ^b   Beer, Ambros J ^c   Grau, Stefan J ^b   Thon, Niklas ^b   Goetz, Claudia ^b   Kretzschmar, Hans A ^a   Tonn, Jörg Christian ^b   Goldbrunner, Roland H ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Angiogenesis; Glioma; Integrin v 3; Integrin immunohistochemistry; Tumor vasculature

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; CD31 ANTIGEN; INTEGRIN; PROTEIN SUBUNIT; VITRONECTIN RECEPTOR; MESSENGER RNA;

ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CELL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; GLIA CELL; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGING; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; TUMOR CELL; TUMOR GROWTH; TUMOR VASCULARIZATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; BRAIN TUMOR; IMAGE PROCESSING; METABOLISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; POLYMERASE CHAIN REACTION; VASCULARIZATION;

ANIMALS; ANTIGENS, CD31; BLOTTING, WESTERN; BRAIN NEOPLASMS; GLIOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHAVBETA3; MICE; NEOVASCULARIZATION, PATHOLOGIC; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 44649103829     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2008.00137.x     Document Type: Article

References (41)

1. Bader BL, Rayburn H, Crowley D, Hynes RO (1998) Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins. Cell 95 : 507 519.
2. Beer AJ, Schwaiger M (2007) Molecular imaging with new PET tracers. Radiologe 47 : 8 17.
3. Beer AJ, Haubner R, Goebel M, Luderschmidt S, Spilker ME, Wester HJ et al (2005) Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients. J Nucl Med 46 : 1333 1341.
4. Beer AJ, Haubner R, Sarbia M, Goebel M, Luderschmidt S, Grosu AL et al (2006) Positron emission tomography using [18F] Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man. Clin Cancer Res 12 : 3942 3949.
5. Bello L, Francolini M, Marthyn P, Zhang J, Carroll RS, Nikas DC et al (2001) Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery. Neurosurgery 49 : 380 389.
6. Bello L, Lucini V, Carrabba G, Giussani C, Machluf M, Pluderi M et al (2001) Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2. Cancer Res 61 : 8730 8736.
7. Bello L, Lucini V, Giussani C, Carrabba G, Pluderi M, Scaglione F et al (2003) IS20I, a specific alphavbeta3 integrin inhibitor, reduces glioma growth in vivo. Neurosurgery 52 : 177 185.
8. Boger DL, Goldberg J, Silletti S, Kessler T, Cheresh DA (2001) Identification of a novel class of small-molecule antiangiogenic agents through the screening of combinatorial libraries which function by inhibiting the binding and localization of proteinase MMP2 to integrin alpha(V)beta(3). J Am Chem Soc 123 : 1280 1288.
9. Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G et al (1994) Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79 : 1157 1164.
10. Brooks PC, Stromblad S, Klemke R, Visscher D, Sarkar FH, Cheresh DA (1995) Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 96 : 1815 1822.
11. Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG et al (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85 : 683 693.
12. Cheresh DA, Spiro RC (1987) Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. J Biol Chem 262 : 17703 17711.
13. Cheresh DA, Stupack DG (2002) Integrin-mediated death: an explanation of the integrin-knockout phenotype? Nat Med 8 : 193 194.
14. Demuth T, Berens ME (2004) Molecular mechanisms of glioma cell migration and invasion. J Neurooncol 70 : 217 228.
15. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA (1995) Definition of two angiogenic pathways by distinct alpha v integrins. Science 270 : 1500 1502.
16. Gladson CL (1996) Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors. J Neuropathol Exp Neurol 55 : 1143 1149.
17. Gladson CL, Cheresh DA (1991) Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. J Clin Invest 88 : 1924 1932.
18. Gladson CL, Wilcox JN, Sanders L, Gillespie GY, Cheresh DA (1995) Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors. J Cell Sci 108 : 947 956.
19. Haubner R, Wester HJ, Reuning U, Senekowitsch-Schmidtke R, Diefenbach B, Kessler H et al (1999) Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting. J Nucl Med 40 : 1061 1071.
20. Haubner R, Weber WA, Beer AJ, Vabuliene E, Reim D, Sarbia M et al (2005) Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD. PLoS Med 2 : e70.
21. Herman IM (1993) Actin isoforms. Curr Opin Cell Biol 5 : 48 55.
22. Hodivala-Dilke KM, McHugh KP, Tsakiris DA, Rayburn H, Crowley D, Ullman-Cullere M et al (1999) Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest 103 : 229 238.
23. Hynes RO (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69 : 11 25.
24. Hynes RO (2002) A reevaluation of integrins as regulators of angiogenesis. Nat Med 8 : 918 921.
25. Kleihues P, Cavenee WK (2000) Pathology and Genetics of Tumours of the Nervous System. Lyon IARC Press : Lyon, France.
26. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC et al (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61 : 215 225.
27. Krebs B, Kohlmannsperger V, Nolting S, Schmalzbauer R, Kretzschmar HA (2006) A method to perform Western blots of microscopic areas of histological sections. J Histochem Cytochem 54 : 559 565.
28. Leary JJ, Brigati DJ, Ward DC (1983) Rapid and sensitive colorimetric method for visualizing biotin-labeled DNA probes hybridized to DNA or RNA immobilized on nitrocellulose: bio-blots. Proc Natl Acad Sci USA 80 : 4045 4049.
29. Macdonald TJ, Taga T, Shimada H, Tabrizi P, Zlokovic BV, Cheresh DA et al (2001) Preferential susceptibility of brain tumors to the antiangiogenic effects of an alpha(v) integrin antagonist. Neurosurgery 48 : 151 157.
30. Ozen O, Krebs B, Hemmerlein B, Pekrun A, Kretzschmar H, Herms J (2004) Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance. Clin Cancer Res 10 : 4746 4753.
31. Paulus W, Tonn JC (1995) Interactions of glioma cells and extracellular matrix. J Neurooncol 24 : 87 91.
32. Paulus W, Baur I, Schuppan D, Roggendorf W (1993) Characterization of integrin receptors in normal and neoplastic human brain. Am J Pathol 143 : 154 163.
33. Priller C, Bauer T, Mitteregger G, Krebs B, Kretzschmar HA, Herms J (2006) Synapse formation and function is modulated by the amyloid precursor protein. J Neurosci 26 : 7212 7221.
34. Reifenberger G, Blümcke I, Pietsch T, Paulus W (2006) Pathology and classification of tumors of the nervous system. In : Neuro-Oncology of CNS-Tumors, JC Tonn, M Westphal, JT Rutka, G Sae (eds), pp. 3 72. Springer : Berlin Heidelberg New York.
35. Reynolds LE, Wyder L, Lively JC, Taverna D, Robinson SD, Huang X et al (2002) Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat Med 8 : 27 34.
36. Ruoslahti E (1991) Integrins. J Clin Invest 87 : 1 5.
37. Silletti S, Kessler T, Goldberg J, Boger DL, Cheresh DA (2001) Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo. Proc Natl Acad Sci USA 98 : 119 124.
38. Taga T, Suzuki A, Gonzalez-Gomez I, Gilles FH, Stins M, Shimada H et al (2002) Alpha v-Integrin antagonist EMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin. Int J Cancer 98 : 690 697.
39. Takano S, Tsuboi K, Tomono Y, Mitsui Y, Nose T (2000) Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression. Br J Cancer 82 : 1967 1973.
40. Wang D, Anderson JC, Gladson CL (2005) The role of the extracellular matrix in angiogenesis in malignant glioma tumors. Brain Pathol 15 : 318 326.
41. Xiong JP, Stehle T, Diefenbach B, Zhang R, Dunker R, Scott DL et al (2001) Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science 294 : 339 345.